Radiolabeled Monoclonal Antibody

This page covers all Radiolabeled Monoclonal Antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Fibroblast Activation Protein (FAP), CD20.

Targets

Fibroblast Activation Protein (FAP) · CD20

Marketed (1)

• [89Zr]Zr-crefmirlimab berdoxam · Pfizer · Oncology

Phase 3 pipeline (1)

• Ibritumomab Tiuxetan + Maintenance · Fondazione Italiana Linfomi - ETS · Oncology
  Ibritumomab tiuxetan is a radiolabeled monoclonal antibody that targets CD20 on B cells and delivers cytotoxic radiation directly to lymphoma cells.

Patent intelligence

• radiolabeled monoclonal antibody patent landscape — aggregated cliff calendar, attackable patents, originator estates